Eribulin Mesylate Injection
Product Images NDC 0143-9167

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 0143-9167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Package (Eribulin Mesylate Injection 1 mg/2 mL Carton)

This is a description of a medication called Eribulin Mesylate Injection, with a concentration of 1 mg/2 mL (0.5 mg/mL). It is a cytotoxic agent used for intravenous administration. The medication comes in single-dose vials, and any unused portion should be discarded. The text also includes details about dosage and usage instructions. The medication is manufactured for Qilu Pharmaceutical Co. in China and distributed by Sandoz Inc. in the United States. The product is labeled with a GNTI barcode and a specific product code.*

FDA Label Image

Figure 1 (Eribulin Fig1)

This is a table showing the survival rates of patients receiving Eribulin Mesylate Injection (N=508) compared to the control group (N=258) over a period of 36 months. The data includes the number of patients at risk at different time points. The information is structured to track the proportion of patients alive over time in both groups.*

FDA Label Image

Figure 2 (Eribulin Fig2)

FDA Label Image

Structural Formula (Eribulin Structure)

FDA Label Image

Principal Display Package (Eribulin Mesylate Injection 1 mg/2 mL Vial Label)

This text provides information about a medication called Eribulin Mesylate Injection, containing 1mg/2mL (0.5mg/mL). It is to be stored at room temperature and intended for intravenous use. The medicine is produced in China and distributed by Jiangxi Qingleng Pharmaceutical Co.Ltd. and Hikma Pharmaceuticals USA Inc. for single-dose vial use. The dosage and usage instructions are specified, including a caution about color agents. The text also mentions the need to discard any unused portion and to avoid freezing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.